Biohit is a Finnish biotechnology company specialising in the development, manufacture and marketing of products and solutions for the early diagnosis and prevention of gastrointestinal and chronic diseases.
We specialize in digestive disease diagnostics, offering a portfolio of unique and patented tests designed to transform clinical practice by making screening, diagnosis and monitoring of gastrointestinal diseases more efficient and cost effective. To learn further on our impact on healthcare and society, please see here.
Our comprehensive diagnostic test range
Our diagnostic prowess extends across a comprehensive range of tests, encompassing both Point-of-Care and laboratory-based solutions. For detailed information about our diagnostic offerings, please see here.
Introducing Acetium®: A breakthrough in gastrointestinal health and smoking cessation
We also have our own unique, patented range of Acetium® products for gastrointestinal health and smoking cessation. Acetium is a Medical Device (EU classification) and is available in pharmacies and supermarkets here.
Events
We will participate in the annual meeting of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) 14.-17.5.2025 in Helsinki !
Read moreWe will participate in Medlab Middle East from 3 to 6 February 2025, an event showcasing the future of laboratory technology.
Read moreMedica , 11.-14. November 2024 Düsseldorf, Germany
Read moreProduct catalogue
Biohit Product Catalogue 2024
Interested?
"*" indicates required fields